Middle East & Africa Liquid Biopsy Market Size & Outlook

Name: Middle East & Africa Liquid Biopsy Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The liquid biopsy market in Middle East & Africa is expected to reach a projected revenue of US$ 431.4 million by 2033. A compound annual growth rate of 9.2% is expected of Middle East & Africa liquid biopsy market from 2026 to 2033.

Clinical Diagnostics
- In Vitro Diagnostics
  - Liquid Biopsy Market Outlook

Middle East & Africa liquid biopsy sample type outlook (Revenue, USD million, 2021-2033)
- Blood Sample Based
- Others
Middle East & Africa liquid biopsy biomarker outlook (Revenue, USD million, 2021-2033)
- Circulating Nucleic Acids
- CTC
- Exosomes/Microvesicles
- Circulating Proteins
Middle East & Africa liquid biopsy technology outlook (Revenue, USD million, 2021-2033)
- Multi-gene-parallel Analysis (NGS)
- Single Gene Analysis (PCR Microarrays)
Middle East & Africa liquid biopsy application outlook (Revenue, USD million, 2021-2033)
- Cancer
  - Lung Cancer
  - Prostate Cancer
  - Breast Cancer
  - Colorectal Cancer
  - Leukemia
  - Gastrointestinal Cancer
  - Others
- Reproductive Health
- Others
Middle East & Africa liquid biopsy end use outlook (Revenue, USD million, 2021-2033)
- Hospitals and Laboratories
- Specialty Clinics
- Academic and Research Centers
- Others
Middle East & Africa liquid biopsy clinical application outlook (Revenue, USD million, 2021-2033)
- Therapy Selection
- Treatment Monitoring
- Early Cancer Screening
- Recurrence Monitoring
- Others
Middle East & Africa liquid biopsy product outlook (Revenue, USD million, 2021-2033)
- Instruments
- Consumables Kits and Reagents
- Software and Services

Middle East & Africa Liquid Biopsy Market Size & Outlook

Data Tree

Sign up - it's easy, and free!